SOPYX | VIVIX | SOPYX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 29 years | 27 years | - |
Gain YTD | 1.843 | 3.211 | 57% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.41B | 184B | 5% |
Annual Yield % from dividends | 1.38 | 2.37 | 58% |
Returns for 1 year | 10.66 | 18.21 | 59% |
Returns for 3 years | 6.13 | 18.46 | 33% |
Returns for 5 years | 24.38 | 44.19 | 55% |
Returns for 10 years | 69.47 | 111.13 | 63% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CGFCX | 65.99 | 0.74 | +1.13% |
American Funds Growth Fund of Amer 529C | |||
AFEIX | 54.04 | 0.45 | +0.84% |
American Century Large Cap Equity I | |||
HLMSX | 16.56 | 0.13 | +0.79% |
Harding Loevner Intl Small Coms Inv | |||
ECEIX | 10.51 | 0.06 | +0.57% |
Lazard Emerging Markets Core Equity Inst | |||
TAISX | 10.34 | 0.03 | +0.29% |
Nuveen Quant Intl Small Cap Eq I |